Phase I study of CMV specific CTL generated from third party for treatment of antiviral drug-resistant CMV infection after allogeneic stem cell transplantatio
Phase 1
- Conditions
- Antiviral drug-resistant CMV infection after allogeneic stem cell transplantation
- Registration Number
- JPRN-UMIN000015556
- Lead Sponsor
- agoya University Graduate School of Medicine, Department of Hematology and Oncology
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete: follow-up complete
- Sex
- All
- Target Recruitment
- 9
Inclusion Criteria
Not provided
Exclusion Criteria
1. Severe or uncontrollable bacterial, fungal,and viral (except CMV) infection 2. Uncontrollable GVHD 3. Uncontrollable heart failure 4. Psychoses 5.History of allergic reaction to albumin
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method